{{Rsnum
|rsid=2284378
|Gene=RALY
|Chromosome=20
|position=34000289
|Orientation=plus
|GMAF=0.225
|Gene_s=RALY
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 47.8 | 43.4 | 8.8
| HCB | 77.4 | 19.7 | 2.9
| JPT | 58.4 | 34.5 | 7.1
| YRI | 72.8 | 25.9 | 1.4
| ASW | 71.9 | 22.8 | 5.3
| CHB | 77.4 | 19.7 | 2.9
| CHD | 65.1 | 28.4 | 6.4
| GIH | 79.2 | 19.8 | 1.0
| LWK | 79.1 | 18.2 | 2.7
| MEX | 51.7 | 41.4 | 6.9
| MKK | 85.9 | 13.5 | 0.6
| TSI | 46.1 | 46.1 | 7.8
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=21983787
|Trait=None
|Title=Genome-wide association study identifies three new melanoma susceptibility loci.
|RiskAllele=G
|Pval=1E-7
|OR=1.2100
|ORtxt=None
|OA=1
}}

{{PMID Auto
|PMID=22976474
|Title=A meta-analysis of genome-wide association studies of breast cancer identifies two novel susceptibility loci at 6q14 and 20q11
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA}}
{{on chip | Illumina Human 1M}}